Alnylam Pharmaceuticals, Inc.
ALNY
$473.29
$8.361.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.00% | 8.87% | 11.00% | 10.46% | 15.54% |
| Total Receivables | 172.65% | 83.25% | 30.08% | 23.65% | 8.73% |
| Inventory | -0.79% | -14.64% | -30.22% | -11.93% | -20.66% |
| Prepaid Expenses | 29.37% | -4.80% | -24.53% | -7.45% | -7.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.80% | 14.84% | 9.36% | 10.48% | 12.39% |
|
|
|||||
| Total Current Assets | 17.80% | 14.84% | 9.36% | 10.48% | 12.39% |
| Net Property, Plant & Equipment | -1.46% | -3.25% | -3.20% | -4.39% | -3.52% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 40.69% | 89.69% | 113.64% | 106.57% | 17.40% |
| Total Assets | 15.38% | 13.88% | 10.18% | 10.71% | 9.53% |
|
|
|||||
| Total Accounts Payable | 66.08% | 38.41% | 24.63% | 59.25% | -4.11% |
| Total Accrued Expenses | 21.93% | 13.64% | 0.76% | 21.45% | 32.68% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.95% | 38.60% | 45.49% | 60.52% | 54.78% |
| Total Finance Division Other Current Liabilities | 74.28% | 96.88% | 90.31% | -8.22% | -7.92% |
| Total Other Current Liabilities | 74.28% | 96.88% | 90.31% | -8.22% | -7.92% |
| Total Current Liabilities | 27.43% | 23.27% | 14.22% | 22.58% | 28.52% |
|
|
|||||
| Total Current Liabilities | 27.43% | 23.27% | 14.22% | 22.58% | 28.52% |
| Long-Term Debt | 1.35% | 0.27% | 0.24% | 0.68% | 1.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -5.34% | -6.23% | -3.27% | -5.58% | -4.72% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 25.37% | 18.60% | -15.27% | -19.84% | -24.82% |
| Total Liabilities | 10.67% | 7.54% | 1.35% | 3.02% | 4.19% |
|
|
|||||
| Common Stock & APIC | 2.13% | 7.97% | 8.93% | 8.47% | 7.76% |
| Retained Earnings | 0.60% | -4.50% | -3.81% | -3.97% | -4.84% |
| Treasury Stock & Other | 12.29% | 13.53% | -39.01% | -47.67% | 23.23% |
| Total Common Equity | 622.92% | 8,270.56% | 152.64% | 130.41% | 119.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 622.92% | 8,270.56% | 152.64% | 130.41% | 119.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 622.92% | 8,270.56% | 152.64% | 130.41% | 119.51% |
|
|
|||||